Viewing Study NCT00784550


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-04-14 @ 7:57 AM
Study NCT ID: NCT00784550
Status: COMPLETED
Last Update Posted: 2016-11-23
First Post: 2008-10-31
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-12
Start Date Type: None
Primary Completion Date: 2009-12
Primary Completion Date Type: ACTUAL
Completion Date: 2009-12
Completion Date Type: ACTUAL
First Submit Date: 2008-10-31
First Submit QC Date: None
Study First Post Date: 2008-11-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2010-11-18
Results First Submit QC Date: None
Results First Post Date: 2010-12-10
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2010-08-17
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2016-10-11
Last Update Post Date: 2016-11-23
Last Update Post Date Type: ESTIMATED